LINCS MCF 10A Common Project: Rolling-time-point sensitivity measures of the MCF 10A breast cell line to 8 small molecule perturbagens. Dataset 2 of 15: End-point cell counts and normalized growth rate inhibition values for all technical replicates of biological replicate 2. - Dataset (ID:20310)
Download: Excel (XLSX), Comma-separated (CSV)
| Cell | Small Molecule | Small Mol Concentration (uM) | Time Point (hr) | Total Cell Count Before Treatment | Total Cell Count After Treatment | Total Control Cell Count | Relative Cell Count | Normalized Growth Rate Inhibition Value | Assay Plate | Assay Well |
|---|---|---|---|---|---|---|---|---|---|---|
| MCF 10A-H2B-mCherry | Dasatinib | 3.1623 | 14.88 | 17.25 | 1 | 534 | 0.0019 | -0.4373 | MN20160310_N02 | C15 |
| MCF 10A-H2B-mCherry | Dasatinib | 3.1623 | 14.88 | 17.25 | 721 | 534 | 1.3491 | 1.1246 | MN20160310_N02 | C15 |
| MCF 10A-H2B-mCherry | Dasatinib | 3.1623 | 14.88 | 17.25 | 3 | 534 | 0.0056 | -0.2975 | MN20160310_N02 | E18 |
| MCF 10A-H2B-mCherry | Dasatinib | 3.1623 | 14.88 | 17.25 | 775 | 534 | 1.4501 | 1.1558 | MN20160310_N02 | E18 |
| MCF 10A-H2B-mCherry | Dasatinib | 3.1623 | 16.85 | 17.25 | 1 | 655 | 0.0015 | -0.4188 | MN20160310_N02 | C15 |
| MCF 10A-H2B-mCherry | Dasatinib | 3.1623 | 16.85 | 17.25 | 733 | 655 | 1.1181 | 1.0430 | MN20160310_N02 | C15 |
| MCF 10A-H2B-mCherry | Dasatinib | 3.1623 | 16.85 | 17.25 | 2 | 655 | 0.0031 | -0.3367 | MN20160310_N02 | E18 |
| MCF 10A-H2B-mCherry | Dasatinib | 3.1623 | 16.85 | 17.25 | 773 | 655 | 1.1791 | 1.0638 | MN20160310_N02 | E18 |
| MCF 10A-H2B-mCherry | Dasatinib | 3.1623 | 18.82 | 17.25 | 1 | 800 | 0.0012 | -0.4022 | MN20160310_N02 | C15 |
| MCF 10A-H2B-mCherry | Dasatinib | 3.1623 | 18.82 | 17.25 | 744 | 800 | 0.9294 | 0.9737 | MN20160310_N02 | C15 |
| MCF 10A-H2B-mCherry | Dasatinib | 3.1623 | 18.82 | 17.25 | 4 | 800 | 0.0050 | -0.2320 | MN20160310_N02 | E18 |
| MCF 10A-H2B-mCherry | Dasatinib | 3.1623 | 18.82 | 17.25 | 778 | 800 | 0.9719 | 0.9897 | MN20160310_N02 | E18 |
| MCF 10A-H2B-mCherry | Dasatinib | 3.1623 | 20.79 | 17.25 | 1 | 1001 | 0.0010 | -0.3849 | MN20160310_N02 | C15 |
| MCF 10A-H2B-mCherry | Dasatinib | 3.1623 | 20.79 | 17.25 | 763 | 1001 | 0.7618 | 0.9092 | MN20160310_N02 | C15 |
| MCF 10A-H2B-mCherry | Dasatinib | 3.1623 | 20.79 | 17.25 | 11 | 1001 | 0.0110 | -0.0739 | MN20160310_N02 | E18 |
| MCF 10A-H2B-mCherry | Dasatinib | 3.1623 | 20.79 | 17.25 | 784 | 1001 | 0.7827 | 0.9181 | MN20160310_N02 | E18 |
| MCF 10A-H2B-mCherry | Dasatinib | 3.1623 | 22.76 | 17.25 | 1 | 1193 | 0.0008 | -0.3725 | MN20160310_N02 | C15 |
| MCF 10A-H2B-mCherry | Dasatinib | 3.1623 | 22.76 | 17.25 | 754 | 1193 | 0.6317 | 0.8552 | MN20160310_N02 | C15 |
| MCF 10A-H2B-mCherry | Dasatinib | 3.1623 | 22.76 | 17.25 | 4 | 1193 | 0.0034 | -0.2127 | MN20160310_N02 | E18 |
| MCF 10A-H2B-mCherry | Dasatinib | 3.1623 | 22.76 | 17.25 | 795 | 1193 | 0.6661 | 0.8714 | MN20160310_N02 | E18 |
| MCF 10A-H2B-mCherry | Dasatinib | 3.1623 | 24.73 | 17.25 | 1 | 1290 | 0.0008 | -0.3672 | MN20160310_N02 | C15 |
| MCF 10A-H2B-mCherry | Dasatinib | 3.1623 | 24.73 | 17.25 | 744 | 1290 | 0.5767 | 0.8307 | MN20160310_N02 | C15 |
| MCF 10A-H2B-mCherry | Dasatinib | 3.1623 | 24.73 | 17.25 | 5 | 1290 | 0.0039 | -0.1804 | MN20160310_N02 | E18 |
| MCF 10A-H2B-mCherry | Dasatinib | 3.1623 | 24.73 | 17.25 | 827 | 1290 | 0.6410 | 0.8621 | MN20160310_N02 | E18 |
| MCF 10A-H2B-mCherry | Dasatinib | 3.1623 | 26.70 | 17.25 | 1 | 1466 | 0.0007 | -0.3587 | MN20160310_N02 | C15 |